Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Suttorp

Showing results (261-270 of 278) with videos related to

Pageof 28
Sort By:
The European Respiratory Journal|March 23, 2023
Cystic fibrosis transmembrane conductance regulator modulators attenuate platelet activation and aggregation in blood of healthy donors and COVID-19 patientsErik Asmus, Weronika Karle, Markus C Brack, et al.
Cell Systems|July 4, 2020
Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 InfectionChristoph B Messner, Vadim Demichev, Daniel Wendisch, et al.
Nature Biotechnology|June 28, 2020
COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysisRobert Lorenz Chua, Soeren Lukassen, Saskia Trump, et al.
Journal of Clinical Immunology|May 5, 2022
Early and Rapid Identification of COVID-19 Patients with Neutralizing Type I Interferon Auto-antibodiesBengisu Akbil, Tim Meyer, Paula Stubbemann, et al.
The American Journal of Tropical Medicine and Hygiene|July 20, 2017
Schistosomiasis in European Travelers and Migrants: Analysis of 14 Years TropNet Surveillance DataTilman Lingscheid, Florian Kurth, Jan Clerinx, et al.
Cell|July 4, 2024
The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulationRainer Knoll, Elisa T Helbig, Kilian Dahm, et al.
Infection|June 15, 2020
Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19)Florian Kurth, Maria Roennefarth, Charlotte Thibeault, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
A SARS-CoV-2 neutralizing antibody protects from lung pathology in a COVID-19 hamster modelJakob Kreye, S Momsen Reincke, Hans-Christian Kornau, et al.
Cell|October 15, 2020
A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster ModelJakob Kreye, S Momsen Reincke, Hans-Christian Kornau, et al.
The European Respiratory Journal|June 21, 2022
Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophagesKatja Hönzke, Benedikt Obermayer, Christin Mache, et al.
Pageof 28

Showing results (261-270 of 278) with videos related to

Sort By:
Pageof 28
The European Respiratory Journal|March 23, 2023
Cystic fibrosis transmembrane conductance regulator modulators attenuate platelet activation and aggregation in blood of healthy donors and COVID-19 patientsErik Asmus, Weronika Karle, Markus C Brack, et al.
Cell Systems|July 4, 2020
Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 InfectionChristoph B Messner, Vadim Demichev, Daniel Wendisch, et al.
Nature Biotechnology|June 28, 2020
COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysisRobert Lorenz Chua, Soeren Lukassen, Saskia Trump, et al.
Journal of Clinical Immunology|May 5, 2022
Early and Rapid Identification of COVID-19 Patients with Neutralizing Type I Interferon Auto-antibodiesBengisu Akbil, Tim Meyer, Paula Stubbemann, et al.
The American Journal of Tropical Medicine and Hygiene|July 20, 2017
Schistosomiasis in European Travelers and Migrants: Analysis of 14 Years TropNet Surveillance DataTilman Lingscheid, Florian Kurth, Jan Clerinx, et al.
Cell|July 4, 2024
The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulationRainer Knoll, Elisa T Helbig, Kilian Dahm, et al.
Infection|June 15, 2020
Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19)Florian Kurth, Maria Roennefarth, Charlotte Thibeault, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
A SARS-CoV-2 neutralizing antibody protects from lung pathology in a COVID-19 hamster modelJakob Kreye, S Momsen Reincke, Hans-Christian Kornau, et al.
Cell|October 15, 2020
A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster ModelJakob Kreye, S Momsen Reincke, Hans-Christian Kornau, et al.
The European Respiratory Journal|June 21, 2022
Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophagesKatja Hönzke, Benedikt Obermayer, Christin Mache, et al.
Pageof 28